Based in Midlothian, YE24 turnover of £191,000. YE24 adjusted EBITDA of £79,000. The company provides operational support for life science firms and other organisations conducting clinical trials. The business is established in the Scottish life sciences ecosystem and maintains trusted relationships across industry, academia, and the NHS. Our client is now offering the company for sale to pursue other unrelated opportunities. Client base encompasses life science companies on a global scale. Maintains a prominent presence in the life science sector for its expertise in oncology, neurology, and psychedelic trials. Utilises a consultant-based model that operates independently of the shareholder, ensuring a smooth transfer of ownership. Strong track record of supporting sponsors transitioning from preclinical to clinical development. Its industry regulation-focused monitoring and protocol adherence services have built client trust and sector reputation. Operates remotely; a fully relocatable opportunity. Offers invited.
- Asking Price:
- Undisclosed
- Turnover:
- £191,000
- Net Profit:
- Undisclosed
